Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Here's a continuation of the webinar content by Dr. Lecia Sequist, who is an Assistant Professor of Medicine at Harvard Medical School and Massachusetts General Hospital (MGH). At the time of her live presentation, she was unable to discuss some very new work that was about to be published on their experience at MGH in repeating biopsies on patients over the course of their ongoing treatment, and the interesting and sometimes treatment-changing results they found.
This second podcast includes her presentation on this very timely information that was, frankly, surprising to many in the lung cancer community, as well as to the investigators themselves. The presentation is in video and audio podcast forms, along with the associated transcript and figures.
[powerpress]
sequist-on-lessons-learned-from-serial-biopsies-audio-podcast
sequist-on-lessons-learned-from-serial-biopsies-transcript
sequist-on-lessons-learned-from-serial-biopsies-figures
We welcome your comments and questions.
The last podcast, which we'll release next week, will include the Q&A session and discussion that followed her presentation.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…
That's beautiful Linda. Thank you,